Press Releases
FDA Extends Review of NDA for Exalgo
Business Wire | 3 days 16 hours 24 minutes ago
Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) has set a new action date under the Prescription Drug User Fee Act for the review of the New Drug Application (NDA) for Exalgo™ (hydromorphone HCl extended-release) Tablets (CII), (Exalgo) of February 22, 2010.... (more)
1
2
16 Press Releases | 
RSS Feed
Sign up for AdvaMed SmartBrief
Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more
Latest Blog Postsview more
Diabetics show alarming increase in morbid obesity
Science Blog
New discovery about the formation of new brain cells
Science Blog
Why not mashed paper towels on the Thanksgiving menu?
Science Blog
Fat around the middle increases the risk of dementia
Science Blog
Job Listingsview more
- Southeast Market Reimbursement Manager
Novasys Medical, Inc. - Senior Quality Manager
St Jude Medical - Principal Manufacturing Engineer - CNC
St Jude Medical - Senior Software Quality Engineer
Covidien - Product Manager, Laparoscopy
Gyrus ACMI - Principal Manufacturing Catheter Engineer
MedVenture Technology - Medical Sales Account Manager
Avery Dennison - Senior Quality Assurance Engineer
Covidien - Director of Marketing- General Surgery
Gyrus ACMI - Principal Healthcare Economics Analyst
Medtronic, INC
Companies in the news
- Asterand PLC
- Becton Dickinson and Company
- Boston Scientific Corp.
- Covidien PLC
- EMPI
- Fluidigm Corporation
- GE Healthcare
- Inovio Biomedical Corp.